Sign in to continue:

Thursday, July 30th, 2026

华夏幸福董事长及核心管理层增持股份进展公告(2026年最新披露)123

华夏幸福基业股份有限公司董事长及核心管理层增持公司股份进展公告详解

华夏幸福基业股份有限公司董事长及核心管理层增持公司股份进展公告

公告要点:

  • 董事长及核心管理层自2026年5月11日起三个月内计划通过上海证券交易所集中竞价方式增持公司股份,增持总金额不低于500万元,不超过600万元。
  • 截至2026年5月18日,已累计增持2,287,000股,占总股本0.059%,增持金额为242.4万元,增持计划尚未完成。
  • 增持主体包括董事长王文学、董事赵威、董事陈怀洲、职工董事庄永、财务总监钟坚、董事会秘书黎毓珊。
  • 增持计划目的是推进公司预重整事项,支持风险化解及持续经营,保障股东及债权人合法权益。
  • 公司实际控制人王文学先生通过直接及间接方式合计持有公司585,418,602股,占总股本15.036%。
  • 增持计划存在资本市场变化及其他不可预见风险,可能导致计划无法持续实施。
  • 增持计划不会导致公司控股股东及实际控制人发生变化。

详细内容:

公司于2026年5月11日披露了董事长及核心管理层增持股份计划,主要目的是积极推进公司预重整相关事项、支持风险化解和持续经营工作,切实保障公司全体股东及债权人的合法权益。此次增持计划未设定价格区间,仅规定增持金额范围:不低于500万元,且不超过600万元,增持方式为通过上海证券交易所系统以集中竞价交易方式进行。

截至2026年5月18日,增持主体已累计增持公司股份2,287,000股,增持金额为242.4万元,约占公司总股本的0.059%。具体增持情况如下:

  • 董事长王文学增持400,100股
  • 董事、总裁赵威增持240,000股
  • 董事、联席总裁陈怀洲增持500,100股
  • 职工董事庄永增持462,000股
  • 财务总监钟坚增持500,000股
  • 董事会秘书黎毓珊增持184,800股

王文学先生作为实际控制人,除直接持有公司股票18,990,700股外,还通过华夏幸福基业控股股份公司及其一致行动人间接持有公司股票566,427,902股,合计持有585,418,602股,占公司总股本的15.036%。

公司提醒,增持计划可能受资本市场波动或其他不可预见风险影响,可能无法持续实施。若出现相关风险,公司将及时披露信息。增持计划不会导致控股股东或实际控制人发生变化,目前增持计划进展正常,未提前终止。

公司董事高管在增持过程中将严格遵守中国证监会及上海证券交易所的相关规定,持续关注增持情况并及时披露信息。


投资者关注要点:

  • 高管增持显示对公司前景及风险化解的信心,或利好股价表现。
  • 增持金额和进展透明,若能持续完成增持计划,或增强市场信心。
  • 计划存在市场风险,投资者需关注后续进展及可能的不确定因素。
  • 实际控制人持股比例高,控股地位稳固。

免责声明:

本文仅为信息披露解读,不构成投资建议。投资者请根据自身情况谨慎决策,注意防范风险。公司增持计划存在因市场变化等因素导致无法持续实施的风险,敬请关注公司后续公告。

Huaxia Happiness Industrial Co., Ltd. Chairman and Core Management Share Purchase Progress Announcement (English)

Key Highlights:

  • Chairman and core management plan to buy company shares via Shanghai Stock Exchange from May 11, 2026, over three months. Total purchase amount: no less than RMB 5 million and no more than RMB 6 million.
  • As of May 18, 2026, a total of 2,287,000 shares purchased (0.059% of total share capital), amounting to RMB 2.424 million. The plan is not yet complete.
  • Participants include Chairman Wang Wenxue, Director Zhao Wei, Director Chen Huaizhou, Employee Director Zhuang Yong, CFO Zhong Jian, Board Secretary Li Yushan.
  • The purpose is to promote restructuring, support risk mitigation and business continuity, and safeguard shareholders’ and creditors’ interests.
  • Actual controller Wang Wenxue holds, directly and indirectly, 585,418,602 shares, representing 15.036% of total share capital.
  • Risks exist: market volatility or unforeseen factors may affect the share purchase plan’s continuation.
  • The plan will not change the controlling shareholder or actual controller.

Details:

On May 11, 2026, the company disclosed a share purchase plan by the chairman and core management, aimed at actively promoting restructuring, supporting risk mitigation and continuous operation, and protecting rights of shareholders and creditors. There is no price range set for the purchase; only the amount range is specified: RMB 5–6 million, via central bidding on the Shanghai Stock Exchange.

By May 18, 2026, a total of 2,287,000 shares had been purchased, totaling RMB 2.424 million, representing 0.059% of total share capital. Breakdown:

  • Chairman Wang Wenxue: 400,100 shares
  • Director/President Zhao Wei: 240,000 shares
  • Director/Co-President Chen Huaizhou: 500,100 shares
  • Employee Director Zhuang Yong: 462,000 shares
  • CFO Zhong Jian: 500,000 shares
  • Board Secretary Li Yushan: 184,800 shares

Wang Wenxue, as actual controller, holds 18,990,700 shares directly and, via Huaxia Happiness Holdings and its concerted parties, 566,427,902 shares indirectly, totaling 585,418,602 shares (15.036%).

The company cautions that the purchase plan may be affected by market changes or unforeseen risks, potentially disrupting implementation. If any risk arises, the company will disclose promptly. The plan does not change the controlling shareholder or actual controller, and progress is normal with no early termination.

Management will comply strictly with regulatory requirements, continuously monitor and disclose progress.


Investor Key Points:

  • Management’s share purchase signals confidence in company prospects and risk resolution, potentially positive for share price.
  • Transparency of purchase amount and progress; completion may boost market confidence.
  • Risks exist; investors should monitor further announcements and uncertainties.
  • High actual controller shareholding, stable control position.

Disclaimer:

This article is for information analysis only and does not constitute investment advice. Investors should make decisions cautiously and be aware of risks. The share purchase plan may be affected by market changes or other factors; please follow subsequent company disclosures.


View *ST华幸 Historical chart here



中化装备科技(青岛)股份有限公司2026年前十大股东及无限售条件股东持股情况公告

中化装备科技(青岛)股份有限公司发布关于回购股份事项前十大股东及前十大无限售条件股东持股情况公告 【要点摘要】 ...

Hunan Fangsheng Pharmaceutical 2025 Dividend Distribution Announcement: Cash Dividend of 0.15 Yuan per Share Details 1

湖南方盛制药股份有限公司2025年年度权益分派实施公告深度解读 公告核心内容与投资者关注要点 湖南方盛制药股份有限公司...

蓝星安迪苏2025年度分红实施公告:每股派0.1元现金红利含税及发放日期说明

安迪苏2025年度权益分派实施公告详解 安迪苏(600299)发布2025年年度权益分派实施公告——分红细节全面解读...